Fujita N - Search Results

1

In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues.

Takahashi Y, Morimura R, Tsukamoto K, Gomi S, Kato A, Mizukami M, Naito Y, Irie S, Nagayama S, Shinozaki E, Yamaguchi K, Fujita N, Kitano S, Katayama R, Matsusaki M. Takahashi Y, et al. Among authors: fujita n. Acta Biomater. 2024 May 25:S1742-7061(24)00276-9. doi: 10.1016/j.actbio.2024.05.037. Online ahead of print. Acta Biomater. 2024. PMID: 38801868

2

[Cryopyrin-associated periodic fever syndrome (CAPS) presenting as early-onset dementia, lacking typical recurrent fever or skin rash: a case report].

Taneda T, Takahashi M, Umeda M, Umeda Y, Oyake M, Nishikomori R, Fujita N. Taneda T, et al. Among authors: fujita n. Rinsho Shinkeigaku. 2024 May 25. doi: 10.5692/clinicalneurol.cn-001956. Online ahead of print. Rinsho Shinkeigaku. 2024. PMID: 38797686 Japanese.

3

[Juvenile-onset anti-nuclear matrix protein 2 (NXP-2) antibody-positive dermatomyositis with joint contractures before manifestation of myositis: a case report].

Miura E, Taneda T, Umeda Y, Umeda M, Oyake M, Matsushita T, Nishino I, Fujita N. Miura E, et al. Among authors: fujita n. Rinsho Shinkeigaku. 2024 May 25. doi: 10.5692/clinicalneurol.cn-001970. Online ahead of print. Rinsho Shinkeigaku. 2024. PMID: 38797685 Japanese.

4

Correlation between the thyroid computed tomography value and thyroid function in hyperthyroidism: a retrospective study.

Iwanaga H, Fujita N, Abe S, Naganawa S, Kato K. Iwanaga H, et al. Among authors: fujita n. Ann Nucl Med. 2024 May 24. doi: 10.1007/s12149-024-01938-0. Online ahead of print. Ann Nucl Med. 2024. PMID: 38787504

5

Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP).

Nakatani S, Kawano H, Sato M, Hoshino J, Nishio S, Miura K, Sekine A, Suwabe T, Hidaka S, Kataoka H, Ishikawa E, Shimazu K, Uchiyama K, Fujimaru T, Moriyama T, Kurashige M, Shimabukuro W, Hattanda F, Kimura T, Ushio Y, Manabe S, Watanabe H, Mitobe M, Seta K, Shimada Y, Kai H, Katayama K, Ichikawa D, Hayashi H, Hanaoka K, Mochizuki T, Nakanishi K, Tsuchiya K, Horie S, Isaka Y, Muto S; JRP collaborators. Nakatani S, et al. Clin Exp Nephrol. 2024 May 11. doi: 10.1007/s10157-024-02509-3. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38734869

6

Efficacy of Health Surveillance and Polymerase Chain Reaction Testing in Judo During the COVID-19 Pandemic.

Sakuyama N, Fujita N, Ikumi A, Miura M, Nagahiro S, Yasuo M. Sakuyama N, et al. Among authors: fujita n. Cureus. 2024 Apr 9;16(4):e57898. doi: 10.7759/cureus.57898. eCollection 2024 Apr. Cureus. 2024. PMID: 38725756 Free PMC article.

7

Impact of severe acute kidney injury on short-term mortality in urosepsis.

Fujita N, Momota M, Soma O, Noro D, Mikami J, Miura Y, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C, Hatakeyama S. Fujita N, et al. World J Urol. 2024 May 8;42(1):301. doi: 10.1007/s00345-024-05018-w. World J Urol. 2024. PMID: 38717511

8

Associations of remaining teeth number, periodontal disease, and occlusal support status with erectile dysfunction in community-dwelling men.

Fujita N, Iwane T, Tamura Y, Okamoto T, Yamamoto H, Hatakeyama S, Yoneyama T, Hashimoto Y, Kobayashi W, Ohyama C. Fujita N, et al. Int J Urol. 2024 May 2. doi: 10.1111/iju.15472. Online ahead of print. Int J Urol. 2024. PMID: 38695270

9

Pembrolizumab response in stage IV luminal-type breast cancer with high microsatellite instability: a case report.

Inakami K, Fujita N, Iguchi C, Enomoto Y, Minohata J, Sata A, Miyagawa Y, Yanagisawa T, Saitoh T, Nomura T, Sawai Y, Takahara K, Kasugai T, Shiba E. Inakami K, et al. Among authors: fujita n. J Med Case Rep. 2024 May 1;18(1):214. doi: 10.1186/s13256-024-04522-2. J Med Case Rep. 2024. PMID: 38689362 Free PMC article.

10

Efficacy and safety of nemolizumab and topical corticosteroids for prurigo nodularis: Results from a randomised, double-blind, placebo-controlled, phase II/III clinical study in patients aged ≥13 years.

Yokozeki H, Murota H, Matsumura T, Komazaki H; Nemolizumab-JP11 Study Group. Yokozeki H, et al. Br J Dermatol. 2024 Apr 17:ljae131. doi: 10.1093/bjd/ljae131. Online ahead of print. Br J Dermatol. 2024. PMID: 38629497

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,585 results

Search Page